|At the 2015 San Antonio Breast Cancer Symposium, Patricia A. Ganz, MD, of the University of California at Los Angeles, discusses a clinical trial of anastrozole vs tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy. IT WAS BETTER
||At the 2015 ASCO Annual Meeting, Christopher Sweeney, MBBS, of Dana-Farber Cancer Institute, and Howard M. Sandler, MD, of Cedars-Sinai Medical Center, discuss the improvement of overall survival in localized, high-risk prostate cancer with the use of adjuvant chemotherapy following androgen suppression and radiotherapy. WAIT UNTIL IT IREALY IS TTME TO TREAT
||At the 2015 ASCO Annual Meeting, Brian I. Rini, MD, of the Cleveland Clinic Taussig Cancer Institute, discusses the results from a phase III study investigating a multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic renal cell carcinoma.
IMMUNOLOGIC THERPAY LEADS THE WAY INN ALSMOST AKK ASPECTS IN MELANOMA